Invitae Corp (NVTAQ)
0.0015
0.00 (0.00%)
USD |
OTCM |
May 06, 15:57
Invitae Research and Development Expense (Quarterly): 58.34M for Sept. 30, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 58.34M |
| June 30, 2023 | 63.82M |
| March 31, 2023 | 61.98M |
| December 31, 2022 | 71.53M |
| September 30, 2022 | 87.18M |
| June 30, 2022 | 115.15M |
| March 31, 2022 | 128.24M |
| December 31, 2021 | 131.76M |
| September 30, 2021 | 97.51M |
| June 30, 2021 | 106.45M |
| March 31, 2021 | 80.36M |
| December 31, 2020 | 72.17M |
| September 30, 2020 | 37.80M |
| June 30, 2020 | 74.96M |
| March 31, 2020 | 55.67M |
| December 31, 2019 | 51.28M |
| September 30, 2019 | 46.95M |
| June 30, 2019 | 25.30M |
| March 31, 2019 | 17.99M |
| December 31, 2018 | 16.57M |
| Date | Value |
|---|---|
| September 30, 2018 | 15.78M |
| June 30, 2018 | 15.78M |
| March 31, 2018 | 15.37M |
| December 31, 2017 | 13.60M |
| September 30, 2017 | 11.50M |
| June 30, 2017 | 11.34M |
| March 31, 2017 | 10.02M |
| December 31, 2016 | 11.78M |
| September 30, 2016 | 11.48M |
| June 30, 2016 | 10.71M |
| March 31, 2016 | 10.66M |
| December 31, 2015 | 11.38M |
| September 30, 2015 | 11.13M |
| June 30, 2015 | 11.84M |
| March 31, 2015 | 8.455M |
| December 31, 2014 | 6.463M |
| September 30, 2014 | 5.557M |
| June 30, 2014 | 5.078M |
| March 31, 2014 | 4.965M |
| December 31, 2013 | 5.418M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
25.30M
Minimum
Jun 2019
131.76M
Maximum
Dec 2021
75.91M
Average
71.85M
Median
Research and Development Expense (Quarterly) Benchmarks
| Laboratory Corp of America Holdings | -- |
| Delcath Systems Inc | 4.709M |
| Star Equity Holdings Inc | -- |
| CytoSorbents Corp | 4.096M |
| Progyny Inc | -- |